Ending the pandemic: How behavioural science can help optimize global COVID-19 vaccine uptake

Michael Vallis; Simon Bacon; Kim Corace; Keven Joyal-Desmarais; Sherri Sheinfeld Gorin; Stefania Paduano; Justin Presseau; Joshua Rash; Abebaw Mengistu Yohannes; Kim Lavoie

doi:10.3390/vaccines10010007

Ending the pandemic: How behavioural science can help optimize global COVID-19 vaccine uptake

Michael Vallis, Simon Bacon, Kim Corace, Keven Joyal-Desmarais, Sherri Sheinfeld Gorin, Stefania Paduano, Justin Presseau, Joshua Rash, Abebaw Mengistu Yohannes, Kim Lavoie

Medicine

Research output: Contribution to journal › Review article › peer-review

17 Citations (Scopus)

Abstract

Governments, public health officials and pharmaceutical companies have all mobilized resources to address the COVID-19 pandemic. Lockdowns, social distancing, and personal protective behaviours have been helpful but have shut down economies and disrupted normal activities. Vaccinations protect populations from COVID-19 and allow a return to pre-pandemic ways of living. However, vaccine development, distribution and promotion have not been sufficient to ensure maximum vaccine uptake. Vaccination is an individual choice and requires acceptance of the need to be vaccinated in light of any risks. This paper presents a behavioural sciences framework to promote vaccine acceptance by addressing the complex and ever evolving landscape of COVID-19. Effective promotion of vaccine uptake requires understanding the context-specific barriers to acceptance. We present the AACTT framework (Action, Actor, Context, Target, Time) to identify the action needed to be taken, the person needed to act, the context for the action, as well as the target of the action within a timeframe. Once identified a model for identifying and overcoming barriers, called COM-B (Capability, Opportunity and Motivation lead to Behaviour), is presented. This analysis identifies issues associated with capability, opportunity and motivation to act. These frameworks can be used to facilitate action that is fluid and involves policy makers, organisational leaders as well as citizens and families.

Original language	English
Article number	7
Journal	Vaccines
Volume	10
Issue number	1
DOIs	https://doi.org/10.3390/vaccines10010007
Publication status	Published - Jan 2022

Bibliographical note

Funding Information:
Funding: M.V., S.B., K.C., K.J.-D., S.S.G, S.P., J.P., J.R., A.M.Y. and K.L. are part of a vaccine working group associated with the International COVID-19 Awareness and Responses Evaluation (iCARE) Study (www.icarestudy.com), which is funded by the Canadian Institutes of Health Research (MS3-173099, co-PI’s: Dr. Simon L. Bacon & Kim L. Lavoie) and the Fonds de Recherche du Québec: Société et Culture (2019-SE1-252541, PI: Dr. Simon L. Bacon). Authors are also supported by the Canada Research Chairs Program (950-232522, Chair holder: Dr. Kim L. Lavoie), a Canadian Institutes of Health Research-Strategy for Patient Oriented Research Mentoring Chair (SMC-151518, PI: Dr. Simon L. Bacon), and a Fonds de Recherche du Québec: Santé Chair (251618, PI: Dr. Simon L. Bacon). None of the funders were involved in the design of the present study.

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

ASJC Scopus Subject Areas

Immunology
Pharmacology
Drug Discovery
Infectious Diseases
Pharmacology (medical)

PubMed: MeSH publication types

Journal Article
Review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/vaccines10010007

Cite this

@article{6d82d6391ba64dc29ba2a7384d310d31,

title = "Ending the pandemic: How behavioural science can help optimize global COVID-19 vaccine uptake",

abstract = "Governments, public health officials and pharmaceutical companies have all mobilized resources to address the COVID-19 pandemic. Lockdowns, social distancing, and personal protective behaviours have been helpful but have shut down economies and disrupted normal activities. Vaccinations protect populations from COVID-19 and allow a return to pre-pandemic ways of living. However, vaccine development, distribution and promotion have not been sufficient to ensure maximum vaccine uptake. Vaccination is an individual choice and requires acceptance of the need to be vaccinated in light of any risks. This paper presents a behavioural sciences framework to promote vaccine acceptance by addressing the complex and ever evolving landscape of COVID-19. Effective promotion of vaccine uptake requires understanding the context-specific barriers to acceptance. We present the AACTT framework (Action, Actor, Context, Target, Time) to identify the action needed to be taken, the person needed to act, the context for the action, as well as the target of the action within a timeframe. Once identified a model for identifying and overcoming barriers, called COM-B (Capability, Opportunity and Motivation lead to Behaviour), is presented. This analysis identifies issues associated with capability, opportunity and motivation to act. These frameworks can be used to facilitate action that is fluid and involves policy makers, organisational leaders as well as citizens and families.",

author = "Michael Vallis and Simon Bacon and Kim Corace and Keven Joyal-Desmarais and Gorin, {Sherri Sheinfeld} and Stefania Paduano and Justin Presseau and Joshua Rash and Yohannes, {Abebaw Mengistu} and Kim Lavoie",

note = "Funding Information: Funding: M.V., S.B., K.C., K.J.-D., S.S.G, S.P., J.P., J.R., A.M.Y. and K.L. are part of a vaccine working group associated with the International COVID-19 Awareness and Responses Evaluation (iCARE) Study (www.icarestudy.com), which is funded by the Canadian Institutes of Health Research (MS3-173099, co-PI{\textquoteright}s: Dr. Simon L. Bacon & Kim L. Lavoie) and the Fonds de Recherche du Qu{\'e}bec: Soci{\'e}t{\'e} et Culture (2019-SE1-252541, PI: Dr. Simon L. Bacon). Authors are also supported by the Canada Research Chairs Program (950-232522, Chair holder: Dr. Kim L. Lavoie), a Canadian Institutes of Health Research-Strategy for Patient Oriented Research Mentoring Chair (SMC-151518, PI: Dr. Simon L. Bacon), and a Fonds de Recherche du Qu{\'e}bec: Sant{\'e} Chair (251618, PI: Dr. Simon L. Bacon). None of the funders were involved in the design of the present study. Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2022",

month = jan,

doi = "10.3390/vaccines10010007",

language = "English",

volume = "10",

journal = "Vaccines",

issn = "2076-393X",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "1",

}

TY - JOUR

T1 - Ending the pandemic

T2 - How behavioural science can help optimize global COVID-19 vaccine uptake

AU - Vallis, Michael

AU - Bacon, Simon

AU - Corace, Kim

AU - Joyal-Desmarais, Keven

AU - Gorin, Sherri Sheinfeld

AU - Paduano, Stefania

AU - Presseau, Justin

AU - Rash, Joshua

AU - Yohannes, Abebaw Mengistu

AU - Lavoie, Kim

N1 - Funding Information: Funding: M.V., S.B., K.C., K.J.-D., S.S.G, S.P., J.P., J.R., A.M.Y. and K.L. are part of a vaccine working group associated with the International COVID-19 Awareness and Responses Evaluation (iCARE) Study (www.icarestudy.com), which is funded by the Canadian Institutes of Health Research (MS3-173099, co-PI’s: Dr. Simon L. Bacon & Kim L. Lavoie) and the Fonds de Recherche du Québec: Société et Culture (2019-SE1-252541, PI: Dr. Simon L. Bacon). Authors are also supported by the Canada Research Chairs Program (950-232522, Chair holder: Dr. Kim L. Lavoie), a Canadian Institutes of Health Research-Strategy for Patient Oriented Research Mentoring Chair (SMC-151518, PI: Dr. Simon L. Bacon), and a Fonds de Recherche du Québec: Santé Chair (251618, PI: Dr. Simon L. Bacon). None of the funders were involved in the design of the present study. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2022/1

Y1 - 2022/1

N2 - Governments, public health officials and pharmaceutical companies have all mobilized resources to address the COVID-19 pandemic. Lockdowns, social distancing, and personal protective behaviours have been helpful but have shut down economies and disrupted normal activities. Vaccinations protect populations from COVID-19 and allow a return to pre-pandemic ways of living. However, vaccine development, distribution and promotion have not been sufficient to ensure maximum vaccine uptake. Vaccination is an individual choice and requires acceptance of the need to be vaccinated in light of any risks. This paper presents a behavioural sciences framework to promote vaccine acceptance by addressing the complex and ever evolving landscape of COVID-19. Effective promotion of vaccine uptake requires understanding the context-specific barriers to acceptance. We present the AACTT framework (Action, Actor, Context, Target, Time) to identify the action needed to be taken, the person needed to act, the context for the action, as well as the target of the action within a timeframe. Once identified a model for identifying and overcoming barriers, called COM-B (Capability, Opportunity and Motivation lead to Behaviour), is presented. This analysis identifies issues associated with capability, opportunity and motivation to act. These frameworks can be used to facilitate action that is fluid and involves policy makers, organisational leaders as well as citizens and families.

AB - Governments, public health officials and pharmaceutical companies have all mobilized resources to address the COVID-19 pandemic. Lockdowns, social distancing, and personal protective behaviours have been helpful but have shut down economies and disrupted normal activities. Vaccinations protect populations from COVID-19 and allow a return to pre-pandemic ways of living. However, vaccine development, distribution and promotion have not been sufficient to ensure maximum vaccine uptake. Vaccination is an individual choice and requires acceptance of the need to be vaccinated in light of any risks. This paper presents a behavioural sciences framework to promote vaccine acceptance by addressing the complex and ever evolving landscape of COVID-19. Effective promotion of vaccine uptake requires understanding the context-specific barriers to acceptance. We present the AACTT framework (Action, Actor, Context, Target, Time) to identify the action needed to be taken, the person needed to act, the context for the action, as well as the target of the action within a timeframe. Once identified a model for identifying and overcoming barriers, called COM-B (Capability, Opportunity and Motivation lead to Behaviour), is presented. This analysis identifies issues associated with capability, opportunity and motivation to act. These frameworks can be used to facilitate action that is fluid and involves policy makers, organisational leaders as well as citizens and families.

UR - http://www.scopus.com/inward/record.url?scp=85121730069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121730069&partnerID=8YFLogxK

U2 - 10.3390/vaccines10010007

DO - 10.3390/vaccines10010007

M3 - Review article

C2 - 35062668

AN - SCOPUS:85121730069

SN - 2076-393X

VL - 10

JO - Vaccines

JF - Vaccines

IS - 1

M1 - 7

ER -

Ending the pandemic: How behavioural science can help optimize global COVID-19 vaccine uptake

Abstract

Bibliographical note

ASJC Scopus Subject Areas

PubMed: MeSH publication types

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this